|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| A61K 31/4709 | (2006.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 17/06 | (2006.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3889145 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21172996.7 |
| Date of filing the European patent application | 2016-12-16 | |
| (97) | Date of publication of the European application | 2021-10-06 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-21 |
| (46) | Date of publication of the claims translation | 2024-04-10 |
| (30) | Number | Date | Country code |
| 201562268765 P | 2015-12-17 | US | |
| 201662353603 P | 2016-06-23 | US |
| (72) |
Sherer, Brian , US
Brugger, Nadia , US
|
| (73) |
Merck Patent GmbH ,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Marija LENKUTIENĖ,
Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius,
LT
|
| (54) | 8-ciano-5-piperidin-chinolinai, kaip TLR7/8 antagonistai ir jų panaudojimas gydant imuninius sutrikimus |
| 8-CYANO-5-PIPERIDINO-QUINOLINES AS TLR7/8 ANTAGONISTS AND THEIR USES FOR TREATING IMMUNE DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2024-10-25 | 9 | 208.00 EUR |
| 2025-12-16 |